Singapore markets closed

BriaCell Therapeutics Corp. (BCTXW)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.3428+0.0125 (+3.78%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/07/2023
31/07/2022
31/07/2021
31/07/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
27,940
15,337
8,021
2,021
2,426
Selling general and administrative
7,328
7,936
7,267
4,955
1,498
Total operating expenses
35,268
23,272
15,286
6,972
3,916
Operating income or loss
-35,268
-23,272
-15,286
-6,972
-3,916
Interest expense
-
0
0.979
78.554
29.48
Total other income/expenses net
28,670
2,079
-11,689
-6,768
-78.901
Income before tax
-6,101
-20,302
-26,839
-13,816
-4,025
Income from continuing operations
-6,101
-20,302
-26,839
-13,816
-4,025
Net income
-5,996
-20,302
-26,839
-13,816
-4,025
Net income available to common shareholders
-5,996
-20,302
-26,839
-13,816
-4,025